skip to Global Navigation Bar skip to main content

homeHome > About Us > Press Release > News


News Content
Daewoong Pharmaceutical successfully held ‘NABOTA SEOUL 2018’
Date 2018-07-06 Hit 1442
News List
Prev Daewoong’s Manufacturing Facility for Nabota acquires EU GMP Approval
Next Daewoong Pharmaceutical’s ‘NABOTA’ becomes the first Korea-made Botulinum Toxin to obtain US FDA approval